Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effect of modulators of protein phosphorylation on the transcriptional activity of the androgen receptor (AR) was studied under transient expression conditions. Activators of protein kinase-A [8-bromo-cAMP (8-Br-cAMP)] and protein kinase-C (phorbol 12-myristate 13-acetate) or an inhibitor of protein phosphatase-1 and -2A (okadaic acid) influenced minimally pMMTV-chloramphenicol acetyl-transferase (CAT) activity in CV-1 cells cotransfected with an AR expression plasmid in the absence of androgen. In the presence of testosterone, however, all compounds enhanced AR-mediated transactivation by 2- to 4-fold. A nonsteroidal antiandrogen, Casodex, behaved as a pure antagonist; it blunted the action of testosterone and was not rendered agonistic by activators of protein kinase-A. A reporter plasmid containing two androgen response elements (AREs) in front of the thymidine kinase promoter (pARE2tk-CAT) was also used to examine promoter specificity. It was activated by 8-Br-cAMP, forskolin, or okadaic acid even without AR or androgen. However, when forskolin or okadaic acid was used together with androgen and AR, the resulting AR-dependent transactivation of pARE2tk-CAT was more than additive. Intact DNA- and ligand-binding domains, but not the N-terminal amino acid residues 40-147, of the receptor were mandatory for the synergism between protein kinase-A activators and androgen. Immunoreactive AR content in transfected COS-1 cells was not influenced by exposure to 8-Br-cAMP. Similar results were obtained by ligand binding assays. Quantitative or qualitative differences were not observed in DNA-binding characteristics between receptors extracted from cells treated with testosterone with or without protein kinase-A activator. Collectively, the synergistic stimulation of AR-dependent transactivation by androgen and protein kinase activators is not due to changes in cellular AR content or affinity of the receptor for the cognate DNA element; rather, this phenomenon seems to result from altered interaction of ligand-activated AR with other proteins in the transcription machinery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor.
Mason, S. A., & Housley, P. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80568-7 · Cited by 94
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
“AR itself does not contain a consensus PKA phosphorylation site and is not directly phosphorylated by PKA (391).”
BackgroundInfluentialZhou, H., S. Beevers, C., & Huang, S. (2011) · Current Drug Targets · doi:10.2174/138945011794815356 · Cited by 715
Yeh, S., Lin, H.-K., Kang, H.-Y., Thin, T. H., Lin, M.-F., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
Grossmann, M. E., Huang, H., & Tindall, D. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1687 · Cited by 548
(2001) · PubMed · Cited by 500
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493
“Abbreviations: T = testosterone, DHT = dihydrotestosterone, 5αR = 5 alpha reductase enzyme, AKR1C = aldoketo reductase, 3α-Diol = 3α-androstanediol, GABA = gamma-aminobutyric acid, GP = gprotein, PKA = protein kinase A, PKC = protein kinase C, CAM = calmodulin, MAPK = mitogen-activated protein kinase, PLC = phospholip…”
BackgroundInfluentialActivation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381
Ikonen, T., Palvimo, J. J., & Jänne, O. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29821 · Cited by 363
Self-citationSteroid hormone receptors and their regulation by phosphorylation
WEIGEL, N. L. (1996) · Biochemical Journal · doi:10.1042/bj3190657 · Cited by 354
Androgen Receptor Phosphorylation
Gioeli, D., Ficarro, S. B., Kwiek, J. J., Aaronson, D., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 351
Ligand-independent activation of steroid hormone receptors
Weigel, N. L., & Zhang, Y. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050241 · Cited by 345
Androgen deprivation therapy for prostate cancer: Current status and future prospects
Miyamoto, H., Messing, E. M., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20115 · Cited by 317
A model of transcriptional regulatory networks based on biases in the observed regulation rules
Harris, S. E., Sawhill, B. K., Wuensche, A., & Kauffman, S. (2002) · Complexity · doi:10.1002/cplx.10022 · Cited by 277
Sadar, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7777 · Cited by 270
Androgen receptor as a target in androgen-independent prostate cancer
Balk, S. P. (2002) · Urology · doi:10.1016/s0090-4295(02)01593-5 · Cited by 264
CREB-binding protein in androgen receptor-mediated signaling
Aarnisalo, P., Palvimo, J. J., & Jänne, O. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2122 · Cited by 255
Self-citationRowan, B. G., Garrison, N., Weigel, N. L., & O'Malley, B. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8720-8730.2000 · Cited by 244
Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A., & Sawyers, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5143 · Cited by 216
Mutual Transcriptional Interference between RelA and Androgen Receptor
Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 214
Self-citation
Metadata
- Authors
- Ikonen, T.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1994-10-01
- Volume
- 135
- Issue
- 4
- Pages
- 1359-1366
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2153042859
- Cited by
- 187
- References
- 1
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.